Cargando…
Preliminary analysis of immune responses in patients enrolled in a Phase II trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod for adjuvant treatment of Stage IIIA or IIIB NSCLC
Autores principales: | Hilton, Traci, Sanborn, Rachel, Boulmay, Brian, Li, Rui, Spieler, Bradley, Happel, Kyle, Paustian, Christopher, Moudgil, Tarsem, Dubay, Christopher, Fisher, Brenda, Mederos, Eileen, Ochoa, Augusto, Urba, Walter J, Hu, Hong-Ming, Fox, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292542/ http://dx.doi.org/10.1186/2051-1426-2-S3-P249 |
Ejemplares similares
-
Preliminary analysis of immune responses in patients enrolled in a Phase II trial of cyclophosphamide with allogenic dribble vaccine alone (DPV-001) or with GM-CSF or imiquimod for adjuvant treatment of stage IIIa or IIIb NSCLC
por: Sanborn, Rachel, et al.
Publicado: (2015) -
Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory t cells
por: Ye, Wei, et al.
Publicado: (2014) -
DPV-001 an autophagosome-enriched cancer vaccine in phase II clinical trials contains 25 putative cancer antigens, DAMPS, HSPS and agonists for TLR 2, 3, 4, 7 and 9
por: Hilton, Traci L, et al.
Publicado: (2013) -
Characterizing the immunoprofile and endogenous immune response to squamous cell carcinomas of the head and neck to guide development of effective immunotherapy strategies
por: Moudgil, Tarsem, et al.
Publicado: (2014) -
Developing an immunotherapy strategy for the effective treatment of patients with squamous cell carcinoma of the head and neck
por: Moudgil, Tarsem, et al.
Publicado: (2013)